Apimeds Pharmaceuticals US Inc. (APUS)
APUS trades on NYSE in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$4.62
-11.15% on the day
Market cap
$7.1M
Nano cap
Revenue
Recent IPO: no annual report filed yet
Net income
Recent IPO: no annual report filed yet
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026.
Profile
| Field | Value |
|---|---|
| Ticker | APUS on NYSE |
| Sector | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations |
| Country | Not reported by the screener |
| IPO year | 2025 |
| SEC CIK | 0001894525 |
| SEC industry code | Pharmaceutical Preparations |
| Incorporated in | DE |
Financials
Recent IPO: no annual report filed yet.
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document PROSPECTUS | 424B4 | 2025-05-09 |
| Latest annual report ANNUAL REPORT | 10-K | 2026-05-04 |
| Latest quarterly / interim QUARTERLY REPORT | 10-Q | 2026-08-14 |
| Latest current report CURRENT REPORT | 8-K | 2026-10-13 |
Source: SEC EDGAR submissions feed, 127 recent filings. All filings on EDGAR.
Peers in Biotechnology: Pharmaceutical Preparations
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| SNGX | Soligenix Inc. | $0.3348 | -4.80% | $7.3M |
| INM | InMed Pharmaceuticals Inc. Common Shares | $1.33 | -2.21% | $7.3M |
| LGVN | Longeveron Inc. | $2.15 | -12.24% | $6.9M |
| SKYE | Skye Bioscience Inc. | $1.53 | -3.17% | $6.8M |
| XCUR | Exicure Inc. | $1.15 | +5.50% | $7.5M |
| APRE | Aprea Therapeutics Inc. | $0.6000 | +1.16% | $7.6M |
| ACXP | Acurx Pharmaceuticals Inc. | $1.20 | -6.25% | $6.7M |
| CALC | CalciMedica Inc. | $1.12 | -7.05% | $7.6M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier